Inclusion Criteria:

- 18 years of age or older

- Patient has received an orthotopic liver transplantation

- Patient meets criteria, as defined per protocol, for being considered at high risk of
developing an invasive fungal infection post-liver transplantation

- For women of childbearing potential, patient must have a negative serum or urine
pregnancy test

Exclusion Criteria:

- Any systemic antifungal therapy (other than fluconazole for a maximum of 7 days)
within 14 days of the administration of the study drug.

- Documented (proven/probable) or suspected (possible) invasive fungal infection at the
time of enrollment.

- Abnormal laboratory values as defined per protocol.

- Allergy, hypersensitivity, or any serious reaction to an echinocandin antifungal.

- Patient not expected to survive at least 5 days.

- Patient is pregnant or breast feeding.